GLP1 MEDICATIONS

Semaglutide & Tirzepatide Available

Semaglutide is a medication used to help improve blood sugar control in adults with type 2 diabetes. It belongs to a class of drugs called GLP-1 receptor agonists. These injections work by increasing insulin secretion, reducing glucagon secretion, and slowing down stomach emptying, which helps lower blood sugar levels. Semaglutide injections are typically given once a week and can be administered under the skin using a prefilled pen device.

It is important to follow your healthcare provider's instructions when using semaglutide injections and to monitor your blood sugar levels regularly. Like any medication, semaglutide injections may have side effects, including nausea, vomiting, diarrhea, and abdominal pain. It is crucial to discuss any concerns or potential side effects with your healthcare provider.

Semaglutide injections are just one part of a comprehensive treatment plan for managing type 2 diabetes, which may also include diet, exercise, and other medications. Always consult with your healthcare provider to determine the best course of treatment for your specific needs.

Medical professional in blue scrubs and blue gloves preparing a syringe with a vaccine or medication.

GLP1 Medications and Weightloss

Semaglutide, a medication originally approved for the treatment of type 2 diabetes, has shown promising results in promoting weight loss. In recent clinical trials, individuals using semaglutide experienced significant weight reduction compared to those on a placebo.

The exact mechanism of how semaglutide aids in weight loss is not fully understood. However, it is believed to act on the area of the brain that regulates appetite and food intake, leading to decreased calorie consumption.

It is important to note that semaglutide is not a standalone solution for weight loss. It should be used in conjunction with a healthy diet and regular exercise for optimal results. Additionally, like any medication, semaglutide may have side effects and is not suitable for everyone. Consulting with a healthcare provider is essential to determine if semaglutide is a safe and effective option for an individual's weight loss journey.

Contact us to schedule your Consultation!

GLP-1 medication consultation aims to provide patients with personalized information and guidance to help them make informed decisions about their diabetes treatment plan and achieve optimal health outcomes. We encourage our patients to ask questions and express any concerns they may have about GLP-1 medications or diabetes management in general.

For additional information check out our FAQ section below

GLP1 MEDICATION FAQs

  • Semaglutide works by mimicking the action of a hormone called GLP-1, which helps regulate blood sugar levels. It increases insulin secretion, decreases glucagon secretion, slows gastric emptying, and promotes satiety.

  • Semaglutide is a medication used to treat type 2 diabetes. It belongs to a class of drugs called glucagon-like peptide-1 (GLP-1) receptor agonists.

  • Semaglutide helps lower blood sugar levels, reduces the risk of cardiovascular events in people with type 2 diabetes and established cardiovascular disease, and may also promote weight loss.

  • Common side effects of Semaglutide may include nausea, vomiting, diarrhea, constipation, abdominal pain, decreased appetite, injection site reactions, hypoglycemia, pancreatitis (rare), thyroid tumors (potential risk), and allergic reactions.

  • Semaglutide is typically administered as a subcutaneous injection once a week. The injection is usually given in the abdomen, thigh, or upper arm.

  • Semaglutide may not be suitable for everyone with type 2 diabetes. It is important to consult with a healthcare professional to determine if Semaglutide is the right treatment option, considering individual health status and medical history.

  • Semaglutide can be used alone or in combination with other diabetes medications, including metformin, sulfonylureas, thiazolidinediones, and insulin. However, the specific combination and dosing should be determined by a healthcare professional.

  • Semaglutide may start to lower blood sugar levels within a few days of starting treatment, but it may take several weeks to see the full effects.

  • Semaglutide is not recommended during pregnancy or breastfeeding due to potential risks to the fetus or infant. Women who are pregnant or planning to become pregnant should discuss alternative treatment options with their healthcare provider.